Skip to main content
  • Important Safety Information
  • Prescribing Information
  • Instructions for Use
  • For US Healthcare Professionals


TYVASO is indicated for pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3), which is high blood pressure in the lungs due to inflammation and sometimes scarring in the lungs. TYVASO can improve the ability to exercise.

Sign up to learn more

Receive updates and support from TYVASO.

*Required Field


By clicking the SUBMIT button, I understand that I am giving United Therapeutics Corporation and its affiliates and business partners permission to use my personal information to provide me with information related to the TYVASO Support Program, as well as treatment options and services provided by United Therapeutics. I understand that United Therapeutics and its contractors will not sell or rent my personal information. I understand I may revoke my permission at any time by clicking the unsubscribe link at the bottom of the page. For more information, please read the Privacy Policy.